Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

PathologyWatch Welcomes Joseph Willman, MD, to Digital Dermatopathology Practice


News Image

PathologyWatch can secure expert opinions from people all over the country in a single afternoon, and that’s revolutionary.

PathologyWatch, a full-service digital dermatopathology solution, welcomes Dr. Joseph Willman, MD, to its team of respected pathologists. Dr. Willman, a dermatopathologist with over two decades of experience, will utilize state-of-the-art digital pathology workflows to deliver optimal patient care to dermatology clinics.

A board-certified pathologist and dermatopathologist, Dr. Willman completed his residency at the University of Utah, his dermatopathology fellowship at the University of Colorado and his molecular genetic pathology fellowship at the University of Michigan.

Dr. Willman’s connection to pathology began long before his career and training. His father was a pathologist, introducing him to the profession at a young age. Still, he expected to follow a different career path. As a student, he spent time working in emergency rooms and found surgery and internal medicine interesting. However, his third-year medical school pathology rotation cemented his interest in pathology, and he now sees digital pathology as the future of the field.

“I think the majority of anatomic pathology will be done digitally, as technology advances to digitize the slides, because it makes it so easy to collaborate, get opinions on cases and implement quality measures to get multiple people reviewing a single case,” Dr. Willman said. “It’s so much more convenient than shipping or using a courier to share glass slides, which is easily a 48-hour process by itself. PathologyWatch can secure expert opinions from people all over the country in a single afternoon, and that’s revolutionary.”

With 20 years of experience in dermatopathology, Dr. Willman brings extensive expertise to PathologyWatch. Most recently, he served as the director of a national reference laboratory and molecular diagnostics lab, where he worked extensively with quality systems and compliance and regulation. His experience and interest in lab operations will help as PathologyWatch builds a digital laboratory platform incorporating quality measures that aren’t possible in a physical laboratory.

“We are thrilled to have Dr. Willman joining our team, not just for the years of experience he has but also for his enthusiasm for the future and commitment to progress and innovation,” said Dan Lambert, CEO at PathologyWatch. “He will be of particular help in moving our molecular efforts forward.”

For more information on PathologyWatch, please visit pathologywatch.com.

About PathologyWatch

PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.

Share article on social media or email:

Mindray North America Unveils New True To Life Vital Signs Monitor


Mindray VS9 Vital Signs Monitor

Mindray VS9 Vital Signs Monitor

Mindray launches new vital signs monitor, the VS9. Loaded with functionality and parameters that provide tools to support clinical decisions, the VS9 offers spot check and continuous vital signs monitoring to help clinicians get a complete picture of patient health.

Mindray, a leading global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced the launch of their new vital signs monitor, the VS9. Loaded with functionality and parameters that provide tools to support clinical decisions, the VS9 offers spot check and continuous vital signs monitoring to help clinicians get a complete picture of patient health. The VS9 Vital Signs Monitor features a 10.1″ touchscreen display and many intuitive tools to enable clinicians to streamline clinical workflow, reduce input errors, improve patient outcomes, and enhance patient satisfaction.

The VS9 Vital Signs Monitor helps clinicians elevate safety, provide true interoperability, and ensure reliability.

Elevate Patient Safety

  •     True to life parameters include non-invasive blood pressure, pulse oximetry, and versatile temperature measurements
  •     Improve patient outcomes with the addition of CO2 for continuous monitoring for early detection of respiratory depression
  •     Validate patient information and store up to 5,000 measurements, accessible by patient ID for easy review
  •     Standard Modified Early Warning Score (MEWS) offers support for clinical decisions

Provide True Interoperability

  •     Improve clinical workflow with configurable workflows defined by department
  •     Streamline department workflow and improve mobility between patients by sending vital signs at the point of care directly to the EHR
  •     Centrally monitor patients with connectivity to the BeneVision Distributed Monitoring System

Offer True Quality and Reliability

  •     Manufactured with durable materials to withstand high-volume medical environments
  •     Built and tested to protect against device deterioration due to chemical exposure

“At Mindray, we understand that the emphasis on patient and clinician safety has never been higher,” said Wayne Quinn, President of Mindray North America. Quinn continued, “Our mission to advance medical technologies to make healthcare more accessible is relevant now more than ever. We are excited to introduce innovative technologies and connectivity tools with the VS9 Vital Signs Monitor to help clinicians maximize patient safety, improve patient outcomes, and increase efficiency in the Med-Surg Unit and beyond.”

The easy-to-use VS9 Vital Signs Monitor offers functionality and parameters to support clinical decisions and elevate your department’s workflow.

V9 Vital Signs Monitor Features and Benefits

  •     TrueBP™ quickly measures blood pressure on inflation in about 15 seconds
  •     BP Averaging functionality provides an average BP over a specified time and a number of measurements
  •     Orthostatic BP helps assess a patient’s fall risk
  •     Customize up to 30 customizable manual inputs, such as respiration rate, glucose, and height
  •     Manual, automatic, and customizable NIBP measurement modes offer flexibility for various clinical applications
  •     Hardwired or wireless configurations available with Bluetooth connectivity

With over 40 years of vital signs monitoring experience, Mindray understands how to deliver clinician-centric, high-value solutions. They offer the industry’s best total cost of ownership, including an industry-leading 3-year warranty for all vital signs products, low acquisition costs, and the ability to deploy on a hospital’s existing network. Through innovative solutions like the VS9 Vital Signs Monitor, Mindray continues to drive its mission forward, advancing medical technologies to make healthcare more accessible.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Strive & Virtua Health Physical Therapy & Rehabilitation Opens New Clinic in Medford


News Image

“This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Medford community. I look forward to helping the community work to achieve their optimal level of function.” – Jackelyn Turner, Medford Clinic Director

Strive & Virtua Health Physical Therapy & Rehabilitation (Strive) is pleased to announce their newest clinic has opened in Medford, NJ. Located at 103 Old Marlton Pike, Suite 111, the clinic is Strive and Virtua’s 5th location.

Jackelyn Turner, PT, DPT, will serve as the Medford Clinic Director and primary treating physical therapist.

Strive specializes in providing exceptional physical therapy through a combination of evidence-based practice, care excellence, and clinical excellence. Specialties from the Medford clinic will include sports injuries, jaw pain, neck & back pain, shoulder & knee pain, pediatrics, concussion injuries, dizziness & balance disorders, and neuromuscular disorders.

“I am excited to be opening this new location in Medford, and to be a part of the Strive team,” says Turner. “This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Medford community. I look forward to helping the community work to achieve their optimal level of function.”

For more information about the new Medford clinic and a full list of Strive’s services and offerings, please visit https://strivephysicaltherapy.com/. To book an appointment with Jackelyn, please call (609) 451-8088 or 1-800-903-4142.

###

About Strive Physical Therapy & Sports Rehabilitation

Strive Physical Therapy & Sports Rehabilitation (Strive) is a Pennsylvania and New Jersey-based, private physical therapy practice group. As a proud member of the Confluent Health family, Strive positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit strivephysicaltherapy.com, or find them on Facebook at @StrivePT.

Share article on social media or email:

Young Living Foundation Announces Ecuador School Expansion, Giving Tuesday Campaign


News Image

“Education is the key to a brighter future, and we’re excited to expand the Academy to welcome even more students in the coming years.”

In the spirit of Giving Tuesday on November 29, The D. Gary Young, Young Living Foundation is excited to announce its service trip to expand the Young Living Academy in Chongón, Ecuador.

More than a dozen attendees will travel to the school from November 15–21 to kick off the expansion with a new preschool music and art building. Service trip attendees will also have the opportunity to spend time with their sponsored students and meet their families during home visits, an experience that sponsors, students, and families alike cherish.

An education at the Academy generates opportunities that are seldom available at other schools in the area—a community where on average only 20 percent of children graduate high school, limiting their income earning potential and prospects in life. From an International Baccalaureate curriculum designed to empower a rising generation of well-rounded changemakers and a variety of extracurricular activities that allow students to explore their passions, to scholarship opportunities that help our graduates pursue their higher education goals, families across the community are eager to send their children to the Academy.

The school has grown from 67 students at its inception in 2009 to its current enrollment of 367. Since its first graduating class in 2016, the school has celebrated 133 graduates, 93 of whom have gone on to pursue higher education opportunities. With the upcoming expansion, the academy hopes to support 1,000 students in the coming years, so even more children can pursue the futures of their dreams.

“The Young Living Academy has served as an education hub and beacon of hope in the Chongón community since its opening,” said Marin Bryce, Executive Director of the Young Living Foundation. “Education is the key to a brighter future, and we’re excited to expand the Academy to welcome even more students in the coming years.”

With the expert support of U.S.-based SSP Architects, the new music and art building will provide additional academic resources for students upon its grand opening at the start of the next school year in May 2023.

“We create buildings and spaces where communities can thrive,” said CEO Jeanne Perantoni from SSP Architects of the Young Living Academy expansion project.

The Young Living Foundation is encouraging those who want to support these efforts to provide academic resources to the surrounding community to consider donating to its Giving Tuesday Campaign or sponsor a student. And because Young Living Essential Oils covers the Foundation’s operating expenses, 100 percent of every contribution will go directly to this project and students in need. To learn more about how you can help, visit the Young Living Academy expansion page.

About Young Living Essential Oils

Young Living Essential Oils, LC, based in Lehi, Utah, is the world leader in essential oils, offering the highest-quality oil-infused products available. Young Living takes its industry leadership seriously, setting the standard with its proprietary Seed to Seal® quality commitment. This guiding principle helps Young Living protect the planet and provide authentic products that its Brand Partners and Customers can feel confident using and sharing with friends and family. Young Living’s products—sourced from corporate-owned farms, partner farms, and other trusted suppliers—not only support a healthy lifestyle, but also provide opportunities for over 6 million global Brand Partners to find a sense of purpose and whole-life wellness by aligning their work with the Young Living values and passions. For more information, visit YoungLiving.com, follow @youngliving on Instagram, or like us on Facebook.

Media Contact

For media inquiries, please contact Maria Coder at maria@redbanyan.com.

Share article on social media or email:



Rimidi Showcases New Module for Respiratory Disease Management at HLTH 2022, Designed to Deliver Better Treatment Decisions


News Image

Digital therapeutics, like the Digihaler® platform, are making new data available to clinicians in the management of complex diseases and we are thrilled to bring that data into the clinical workflow as part of our platform.”

Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, announced today the launch of its new Respiratory Module, designed to give providers a more complete view of the patient in order to guide treatment decisions for those with respiratory diseases. As part of the new module, patient data from connected pulse oximeters and—via a newly announced collaboration with Teva Pharmaceuticals—digital inhalers will be integrated into healthcare provider workflows, enhancing respiratory care and population health management.

Over 500 million people globally suffer from respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). In many cases, patients with these respiratory conditions also have cardiometabolic disorders like hypertension, obesity and diabetes, which can create additional health complications and lead to greater healthcare expenses. Rimidi’s Respiratory Module, which complements the company’s full suite of disease modules, allows providers to comprehend the full picture of the patient’s disease status both in the clinic and at home. As a result, staff are better empowered and equipped to make personalized, predictive care decisions and improve outcomes.

“Given that chronic respiratory conditions like asthma and COPD share many similarities with the cardiometabolic conditions that Rimidi already supports, such as the burden of daily home self-management and complex treatment guidelines, launching respiratory as our newest disease module made sense,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Digital therapeutics, like the Digihaler® platform, are making new data available to clinicians in the management of complex diseases and we are thrilled to bring that data into the clinical workflow as part of our platform.”

“The digital therapeutics space is growing as healthcare continues to modernize, and our team is working hard to make the use of digital therapeutics seamless for healthcare providers and the patients they serve,” said Manny Montalvo, SVP, Head of Digital Health & Innovation at Teva Pharmaceuticals. “We’re excited to integrate with Rimidi and leverage our innovative technologies together to further fulfill our mission of improving the lives of patients.”

For more information on Rimidi’s Respiratory Disease Management Module visit http://www. rimidi.com/respiratory.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient-reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic, biosimilar and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at http://www.tevapharm.com.

About Teva Digital Health

Teva aims to be a global leader in personalized, predictive care, continuously investing in platforms and regulatory-compliant systems that will change the nature of digital health as we know it to improve the lives of patients across the world. By leveraging. Teva’s proprietary software platform Digihaler® – developed and maintained in house by a team of research specialists and programmers – is built into a series of FDA and EMA-approved inhalers, currently marketed in North America and Europe.

Share article on social media or email:



Houstonia Magazine Names McGovern Allergy & Asthma Clinic Doctors Top Allergists in Houston


McGovern Allergists Named Top Doctors

McGovern Allergists Named Top Doctors

“The opportunity to help relieve a patient’s symptoms and improve their well-being is why we got into the field in the first place. We look forward to continuing to provide the best allergy and asthma care to our patients in the years to come.” – Dr. Aries Gavino & Dr. Serge De Golovine

Houstonia Magazine recently announced its Top Doctors of 2022 list. Among those awarded were McGovern Allergy & Asthma Clinic’s allergists, Dr. Aries Gavino and Dr. Serge De Golovine. The two physicians were named top doctors in their specialty of allergy and immunology.

To curate their list of the top doctors in the community, Houstonia Magazine put out a call for nominations to over 15,000 board-certified doctors in the greater Houston area. Their nomination form asked each doctor to recommend physicians to whom they would entrust their own families. After the nominations were tallied, Houstonia compiled a list of top vote recipients in each specialty, making certain that all physicians were currently certified by their respective medical licensing boards. The 2022 list marks Houstonia’s tenth year running the survey.

Dr. Gavino joined McGovern Allergy and Asthma in 2014. He is board certified in Allergy and Immunology as well as Internal Medicine. Dr. Gavino specializes in a broad spectrum of allergic and immunologic conditions, including asthma, sinus diseases, primary immunodeficiencies, urticaria, angioedema, and food, drug, and environmental allergies.

Dr. De Golovine joined the practice in 2013 and is board-certified in adult and pediatric Allergy and Immunology, as well as in Rheumatology and Internal Medicine. He specializes in asthma, sinusitis, food allergies, and skin rashes using a personalized, holistic approach.

About being named top allergists in Houston, the McGovern physicians said, “We were humbled to be recognized with this award. To know our efforts to provide quality patient care are valued by our community is a great feeling.” They continued, “The opportunity to help relieve a patient’s symptoms and improve their well-being is why we got into the field in the first place. It is a joy for us to be a part of the Houston community. We look forward to continuing to provide the best allergy and asthma care to our patients in the years to come.”

To learn more about Houstonia Magazine’s Top Doctors list, visit http://www.houstoniamag.com/health-and-wellness/2022/05/houstons-top-doctors.

To learn more about McGovern Allergy & Asthma Clinic’s list of services or to request an appointment with a physician, visit https://www.mcgovernallergy.com.

About McGovern Allergy & Asthma Clinic

McGovern Allergy and Asthma Clinic providers specialize in the diagnosis and treatment of allergic diseases in adults and children caused by a broad spectrum of allergens. The clinic was founded in 1956 by John P. McGovern, an internally noted physician, and has maintained its reputation in the Houston community as one of the top allergy clinics. The board-certified allergists and staff continue their pioneering treatment of allergies and allergy-related diseases from a modern facility in Houston, TX, at 4710 Bellaire Boulevard at Loop 610 West.

Share article on social media or email:

Zappix Launched Referral Management Service with a Healthcare Provider to Improve Patient Leakage


News Image

We are excited to see that the Patient Referral Management service is helping healthcare providers improve the patient leakage, We are continuously enhancing the Zappix Digital Patient Engagement Solution, and allow our healthcare clients to improve Patient Experience while driving automation and…

Zappix has deployed an automated digital engagement solution that reminds patients of their referrals, explains the importance of those procedures, and drives the scheduling of appointments. The service has replaced a costly manual workflow and has shown significant improvement in booked appointments. Zappix’s Referral Management solution was implemented to proactively connect patients with referrals to a simple solution for booking appointments right from their fingertips.

Zappix’s solution automates the process of transforming a referral to a scheduled patient. The automated solution replaces the need for providers to have staff call each referral multiple times until they reach them to book an appointment. The service automatically sends digital messages in high volumes, lowering staff effort and increasing the number of scheduled appointments.

The benefits of the Referral Management solution are clear – higher booked appointments rate at a much lower effort and cost for the organization.

“We are excited to see that the Patient Referral Management service is helping healthcare providers improve the patient leakage,” said Yossi Abraham, Zappix President & CEO. “We are continuously enhancing the Zappix Digital Patient Engagement Solution, and allow our healthcare clients to improve Patient Experience while driving automation and efficiency of key workflows.”

Zappix clients are seeing over 60% of their patients are converting from a referral to a booked appointment using the Referral Management solution. The use of engaging content, timely reminders, informative graphics, and an easy-to-navigate interface encourages patients to book appointments they have yet to schedule by informing them of the importance of the appointment and making the process simple from any device.

About Zappix

Zappix transforms the patient journey with easy-to-use, modern digital patient engagement tools to improve the quality of care and increase patient satisfaction and loyalty. The cloud-based solutions enable workflow automation, rapid developments, seamless integration to EMRs & back-end systems, and provide a comprehensive Analytics Suite.

Zappix provides significant benefits and ROI by improving quality of care, increasing patient satisfaction and loyalty, improving financial outcomes, and increasing hospitals’ competitive advantage and positioning.

To learn more about Zappix, go to healthcare.zappix.com.

Contact

Zappix, Inc.

marketing@zappix.com

(781) 739-2770

Payge Wufsus

payge.wufsus@zappix.com

Share article on social media or email:

Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond, Upcoming Webinar Hosted by Xtalks


A case study is presented to link acceptable RT-qPCR validation performance with the efficacy of the Moderna Phase 3 COVID-19 vaccine.

The challenges of developing and validating qPCR assays in vaccine and therapeutic trials are manifold and hampered by a lack of harmonization of CRO’s.

The webinar will explore the advantages of qPCR in advancing life-enhancing therapeutics and why patients deserve the effort to harmonize. Validation performance characteristics are explored with a special focus on precision and sensitivity. Regarding precision, acceptable values for percent coefficient of variation is not clearly defined in the scientific literature or health agency publications. Uncertainty around precision is exacerbated by qPCR CV’s that are commonly higher than other traditional bioanalysis assays (e.g., ligand binding and chromatographic assays). Regarding sensitivity, the selection of PCR is based on its exceptional sensitivity (and specificity). Yet there is a lack of clarity around how to measure this and what the minimal requirements are.

The best practices and strategies for optimizing assays are discussed as is the importance of assay context of use in deciding acceptable precision and sensitivity. In-house summaries from analyses of more than 50 qPCR validations as well as experimental data comparing bead- vs column-based extraction will be presented. Finally, a case study is presented to link acceptable RT-qPCR validation performance with the efficacy of the Moderna Phase 3 COVID-19 vaccine.

Register for this webinar to learn the opportunities and challenges of developing and validating qPCR assays in vaccine and therapeutic trials.

Join Mark Wissel, PhD, Director of Research & Development, Eurofins Viracor Biopharma, for the live webinar on Thursday, December 8, 2022, at 1pm EST (10am PST).

For more information, or to register for this event, visit Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Cincinnati Foot & Ankle Care partners with Beyond Podiatry


Cincinnati Foot & Ankle Care (“CFAC”), one of the largest independent podiatry groups in Ohio, has partnered with Beyond Podiatry, one of the largest podiatry practice management organizations in the Midwest and a portfolio company of Albaron Partners, LP. Founded in 1998, CFAC is a leading podiatric medical practice of nineteen (19) experienced foot & ankle surgeons with several clinics in the Greater Cincinnati area. “We are excited to be part of the Beyond Podiatry family”, said Nickolas A. Minnie, DPM, managing partner of CFAC, “we believe that the future growth and success of CFAC with Beyond Podiatry will be transformative in our industry while providing optimal patient experiences and efficiencies in our quality of care.” For John Moroney, Beyond Podiatry’s President, this marked another milestone in the company’s strategic partnership with best-in-class podiatry practices, noting “we are extremely excited about this transformational partnership with CFAC as it solidifies our position as the leading podiatry platform in the Midwest.”

The terms of the transaction were not disclosed.

ABOUT CINCINNATI FOOT & ANKLE CARE

Founded in 1998 and based in Cincinnati, OH, Cincinnati Foot & Ankle Care is Greater Cincinnati’s leading podiatry practice of foot & ankle surgeons committed to providing the highest quality of care and treatment for all types of foot and ankle injuries and conditions for patients of all ages. For more information, please visit: http://www.cfac.net

ABOUT BEYOND PODIATRY

Beyond Podiatry provides patients with the most advanced and comprehensive foot and ankle care treatment options to meet their personalized needs. As a team, they combine the skills of some of the premier podiatric medicine experts in the country and seasoned operating professionals with experience in running large healthcare organizations. For more information, please visit: http://www.beyond-podiatry.com

ABOUT ALBARON

Albaron is a U.S. private equity firm that invests in and helps accelerate the growth of physician practice groups and microcap healthcare companies. The firm’s goal is to build best-in-class healthcare services platforms that maximize outcomes for all constituents – patients, providers, payors and investors. Albaron’s team is comprised of a seasoned cohort of operating experts and investment professionals who are uniquely qualified to realize significant value through strategic insights, operating support and accretive acquisitions. The team works collaboratively with partnering management teams and leverages its network of industry experts to augment its capabilities. For more information, please visit: http://www.albaronpartners.com

CONTACT:

Beyond Podiatry

John Moroney

President and Chief Operating Officer

john.moroney@beyond-podiatry.com

Albaron Partners, LP

Alessio Baraldi

Partner

alessio@albaronpartners.com

Debo Adesina

Partner

debo@albaronpartners.com

FORWARD-LOOKING STATEMENTS

This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties, including statements regarding expectations about the business of Beyond Podiatry. If any of these risks or uncertainties materialize, or if such assumptions prove incorrect, financial or operational results of Albaron Partners and its affiliates, including Beyond Podiatry, could differ materially from the results expressed or implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to Albaron Partners and its affiliates, including Beyond Podiatry, as of the date of this communication, and none of Albaron Partners or any of its affiliates, including Beyond Podiatry, assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by applicable law.

Share article on social media or email:

Design with the End in Mind, Upcoming Webinar Hosted by Xtalks


With this approach, SDTM conversions can be done as soon as patient data is collected.

Since the FDA passed regulations requiring submitted datasets to be compliant with the CDISC Study Data Tabulation Model (SDTM), clinical trial sponsors have faced a dilemma. Should they design electronic case report forms (eCRFs) in line with SDTM from the outset? Or should they retrospectively convert data to CDISC SDTM at the end?

A retrospective approach is fraught with risk. What if some of the required data is missing? Will it be possible to retrofit datasets and terminology into the CDISC SDTM and NCI Controlled Terminology models? Will the submission be compliant?

This time-consuming data wrangling distracts resources from the important business of delivering a high quality submission package – before the deadline!

In this presentation, we discuss a ‘designing with the end in mind’ approach. This includes: Designing optimal data collection eCRFs which balance ease of data collection whilst aligning to SDTM and NCI CT requirements; And designing target SDTM datasets and mapping these to raw datasets upfront.

The big win?

With this approach, SDTM conversions can be done as soon as patient data is collected. Plus, conversions can be run throughout the trial, allowing clinicians to analyze and visualize data immediately, and make timely safety and efficacy decisions.

Now continuous quality monitoring during a study is possible. Coupled with the benefits of early data visibility, this will speed therapies to market faster than ever before.

Register for this webinar and hear from leading industry experts about designing studies with the end in mind — and how technology can be leveraged to facilitate this.

Join Scott Robertson, Vice President Sales, Global Partnerships, Mednet; Mark Wheeldon, CEO, Formedix; and Ed Chappell, Solutions Consultant, Formedix, for the live webinar on Thursday, December 01, 2022, at 1pm EST (10am PST).

For more information, or to register for this event, visit How To Accelerate & Improve the Quality of CDISC SDTM Deliverables: Design with the End in Mind.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: